Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy Article

Dimitroff, CJ, Klohs, W, Sharma, A et al. (1999). Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy . INVESTIGATIONAL NEW DRUGS, 17(2), 121-135. 10.1023/A:1006367032156

Industry Collaboration

cited authors

  • Dimitroff, CJ; Klohs, W; Sharma, A; Pera, P; Driscoll, D; Veith, J; Steinkampf, R; Schroeder, M; Klutchko, S; Sumlin, A; Henderson, B; Dougherty, TJ; Bernacki, RJ

sustainable development goals

authors

publication date

  • May 1, 1999

webpage

published in

keywords

  • BLADDER
  • BREAST-CANCER
  • CANCER METASTASIS
  • CELL-CARCINOMA
  • GROWTH
  • HEMATOPORPHYRIN
  • IN-VITRO
  • Life Sciences & Biomedicine
  • MICROCIRCULATION
  • Oncology
  • Pharmacology & Pharmacy
  • SERIES
  • Science & Technology
  • VASCULAR DEVELOPMENT
  • angiogenesis
  • cytostatic chemotherapy
  • inhibitors
  • tyrosine kinase

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 121

end page

  • 135

volume

  • 17

issue

  • 2